Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 3,243 | 3,731 | 2,578 | 2,703 | 822 |
| Gross Profit | 3,243 | 3,731 | 2,578 | 2,703 | 822 |
| Operating Expenses | 26,215 | 19,053 | 19,329 | 16,636 | 10,978 |
| Operating Income | -22,972 | -15,322 | -16,751 | -13,933 | -10,156 |
| Interest Expense | 0 | 0 | 0 | 0 | 599 |
| Other Income | -1,561 | -1,417 | -1,576 | -915 | -557 |
| Pre-tax Income | -24,533 | -16,739 | -18,327 | -14,848 | -11,312 |
| Income Tax | 109 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -24,642 | -16,739 | -18,327 | -14,848 | -11,312 |
| Net Income | $-24,642 | $-16,739 | $-18,327 | $-14,848 | $-11,312 |
| EPS Basic Total Ops | -1.93 | -7.71 | -8.37 | -7.20 | -5.49 |
| EPS Basic Continuous Ops | -1.93 | -7.71 | -8.37 | -7.20 | -5.49 |
| EPS Diluted Total Ops | -1.93 | -7.71 | -8.37 | -7.20 | -5.49 |
| EPS Diluted Continuous Ops | -1.93 | -7.71 | -8.37 | -7.20 | -5.49 |
| EBITDA(a) | $-20,984 | $-14,075 | $-15,336 | $-13,006 | $-9,315 |